Bintrafusp functions as a TGFβ “trap”, resulting in a combined reduction in TGFβ signaling within the TME and inhibition of the immune checkpoint with anti-PD-L1 action that reduced tumor growth to a greater extent than either element individually (Figure 1C) [108]. This evidence concerns the gene CD274 and neoplasm.